Erectile dysfunction startup raises $88M for another hard problem
Ro, previously known as Roman, has raised the new money to launch a smoking cessation vertical called Zero.
Chrono Therapeutics raises $47.6M for smoking cessation wearable to deliver nicotine fix before you wake
Chrono Therapeutics will use the funding to support clinical trials of the wearable device in the U.S. and Europe to wean smokers off cigarettes using timed delivery of nicotine.
presented by
Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
Chrono Therapeutics nets Rock Health investment for smoking cessation wearable
Rock Health entered the arena of digital health tools for smoking cessation with an investment in Chrono Therapeutics, according to a company statement. The pharmaceutical company produces a wearable drug delivery tool and companion app called SmartStop, which functions as a digital health coach to help smokers quit. The investment follows a $32 million Series […]